XML 52 R42.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2024
Disaggregation of Revenue [Line Items]  
Schedule of Condensed Income Statement by Segment

Condensed Statements of Operations

Three Months Ended June 30, 2024

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

1,966

$

212

$

105

$

10

$

44

$

25

$

$

2,362

Other revenues from operations

 

 

 

171

 

 

19

 

 

1

 

 

191

Net loss from investment activities

 

(479)

 

 

 

 

 

 

 

 

(479)

Interest and dividend income

 

87

 

7

 

1

 

 

 

 

1

 

26

 

122

Gain on disposition of assets, net

 

 

 

1

 

 

 

 

 

 

1

Other income, net

 

 

4

 

 

 

 

 

 

 

4

 

(392)

 

1,977

 

385

 

105

 

29

 

44

 

27

 

26

 

2,201

Expenses:

Cost of goods sold

 

 

1,922

 

142

 

86

 

7

 

33

 

14

 

 

2,204

Other expenses from operations

 

 

 

136

 

 

18

 

 

 

 

154

Dividend expense

 

13

 

 

 

 

 

 

 

 

13

Selling, general and administrative

 

6

 

35

 

99

 

11

 

4

 

11

 

10

 

7

 

183

Restructuring, net

1

1

Interest expense

 

19

 

26

 

1

 

3

 

 

 

 

79

 

128

 

38

 

1,983

 

378

 

101

 

29

 

44

 

24

 

86

 

2,683

(Loss) income before income tax (expense) benefit

 

(430)

 

(6)

 

7

 

4

 

 

 

3

 

(60)

 

(482)

Income tax benefit (expense)

 

 

31

 

 

(2)

 

 

 

 

(33)

 

(4)

Net (loss) income

 

(430)

 

25

 

7

 

2

 

 

 

3

 

(93)

 

(486)

Less: net (loss) income attributable to non-controlling interests

 

(173)

 

17

 

 

1

 

 

 

 

 

(155)

Net (loss) income attributable to Icahn Enterprises

$

(257)

$

8

$

7

$

1

$

$

$

3

$

(93)

$

(331)

Supplemental information:

Capital expenditures

$

$

43

$

12

$

3

$

7

$

1

$

$

$

66

Depreciation and amortization

$

$

90

$

18

$

7

$

4

$

1

$

7

$

$

127

Three Months Ended June 30, 2023

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

2,237

$

248

$

117

$

13

$

46

$

23

$

$

2,684

Other revenues from operations

 

 

 

177

 

 

20

 

 

1

 

 

198

Net loss from investment activities

 

(500)

 

 

 

 

 

 

 

 

(500)

Interest and dividend income

 

134

 

8

 

 

 

 

 

 

25

 

167

Gain on disposition of assets, net

 

 

 

3

 

 

 

 

 

 

3

Other income, net

 

1

 

3

 

 

1

 

1

 

 

1

 

 

7

 

(365)

 

2,248

 

428

 

118

 

34

 

46

 

25

 

25

 

2,559

Expenses:

Cost of goods sold

 

 

1,990

 

173

 

90

 

8

 

35

 

14

 

 

2,310

Other expenses from operations

 

 

 

142

 

 

18

 

 

 

 

160

Dividend expense

 

19

 

 

 

 

 

 

 

 

19

Selling, general and administrative

 

13

 

39

 

114

 

15

 

5

 

10

 

11

 

8

 

215

Credit loss on related party note receivable

116

116

Loss on deconsolidation of subsidiary

20

20

Interest expense

38

22

1

3

72

136

 

70

 

2,051

 

430

 

108

 

31

 

45

 

25

 

216

 

2,976

(Loss) income before income tax (expense) benefit

 

(435)

 

197

 

(2)

 

10

 

3

 

1

 

 

(191)

 

(417)

Income tax (expense) benefit

 

 

(41)

 

6

 

(5)

 

 

 

 

38

 

(2)

Net (loss) income

 

(435)

 

156

 

4

 

5

 

3

 

1

 

 

(153)

 

(419)

Less: net (loss) income attributable to non-controlling interests

 

(220)

 

70

 

 

 

 

 

 

 

(150)

Net (loss) income attributable to Icahn Enterprises

$

(215)

$

86

$

4

$

5

$

3

$

1

$

$

(153)

$

(269)

Supplemental information:

Capital expenditures

$

$

56

$

11

$

5

$

$

1

$

$

$

73

Depreciation and amortization

$

$

89

$

22

$

7

$

3

$

1

$

7

$

$

129

Six Months Ended June 30, 2024

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

    

Consolidated

(in millions)

Revenues:

Net sales

$

$

3,829

$

431

$

206

$

11

$

80

$

49

$

$

4,606

Other revenues from operations

 

 

 

336

 

 

36

 

 

2

 

 

374

Net loss from investment activities

 

(575)

 

 

 

 

 

 

 

 

(575)

Interest and dividend income

 

192

 

20

 

2

 

 

 

 

1

 

50

 

265

Loss on disposition of assets, net

 

 

(1)

 

(4)

 

 

 

 

 

 

(5)

Other income (loss), net

 

 

8

 

 

(2)

 

 

 

 

 

6

 

(383)

 

3,856

 

765

 

204

 

47

 

80

 

52

 

50

 

4,671

Expenses:

Cost of goods sold

 

 

3,635

 

294

 

166

 

8

 

60

 

28

 

 

4,191

Other expenses from operations

 

 

 

275

 

 

32

 

 

 

 

307

Dividend expense

33

 

 

 

 

 

 

 

 

33

Selling, general and administrative

 

10

 

77

 

201

 

24

 

9

 

21

 

20

 

14

 

376

Restructuring, net

1

1

Interest expense

 

44

 

59

 

1

 

6

 

 

 

 

154

 

264

 

87

 

3,771

 

771

 

197

 

49

 

81

 

48

 

168

 

5,172

(Loss) income before income tax (expense) benefit

 

(470)

 

85

 

(6)

 

7

 

(2)

 

(1)

 

4

 

(118)

 

(501)

Income tax benefit (expense)

 

 

18

 

4

 

(3)

 

 

 

 

(30)

 

(11)

Net (loss) income

 

(470)

 

103

 

(2)

 

4

 

(2)

 

(1)

 

4

 

(148)

 

(512)

Less: net (loss) income attributable to non-controlling interests

 

(190)

 

46

 

 

1

 

 

 

 

 

(143)

Net (loss) income attributable to Icahn Enterprises

$

(280)

$

57

$

(2)

$

3

$

(2)

$

(1)

$

4

$

(148)

$

(369)

Supplemental information:

Capital expenditures

$

$

90

$

28

$

5

$

9

$

2

$

$

$

134

Depreciation and amortization

$

$

182

$

37

$

13

$

7

$

3

$

14

$

$

256

Six Months Ended June 30, 2023

    

Investment

    

Energy

    

Automotive

    

Food Packaging

    

Real Estate

    

Home Fashion

    

Pharma

    

Holding Company

 

Consolidated

(in millions)

 

Revenues:

    

  

  

  

  

  

  

  

  

 

  

Net sales

$

$

4,523

$

535

$

235

$

20

$

86

$

43

$

$

5,442

Other revenues from operations

 

 

 

347

 

 

36

 

 

2

 

 

385

Net loss from investment activities

 

(943)

 

 

 

 

 

 

 

 

(943)

Interest and dividend income

 

278

 

13

 

 

 

 

 

 

47

 

338

Gain on disposition of assets, net

 

 

3

 

 

 

 

 

 

3

Other income (loss), net

 

1

 

6

 

 

(6)

 

1

 

 

1

 

 

3

 

(664)

 

4,542

 

885

 

229

 

57

 

86

 

46

 

47

 

5,228

Expenses:

 

Cost of goods sold

 

 

3,916

 

366

 

181

 

14

 

67

 

26

 

 

4,570

Other expenses from operations

 

 

 

287

 

 

31

 

 

 

 

318

Dividend expense

 

47

 

 

 

 

 

 

 

 

47

Selling, general and administrative

 

16

 

85

 

246

 

29

 

9

 

20

 

24

 

15

 

444

Credit loss on related party note receivable

116

116

Loss on deconsolidation of subsidiary

 

246

246

Interest expense

 

83

 

45

 

1

 

6

 

 

 

 

143

 

278

 

146

 

4,046

 

900

 

216

 

54

 

87

 

50

 

520

 

6,019

(Loss) income before income tax (expense) benefit

 

(810)

 

496

 

(15)

 

13

 

3

 

(1)

 

(4)

 

(473)

 

(791)

Income tax (expense) benefit

 

 

(93)

 

6

 

(1)

 

 

 

 

102

 

14

Net (loss) income

 

(810)

 

403

 

(9)

 

12

 

3

 

(1)

 

(4)

 

(371)

 

(777)

Less: net (loss) income attributable to non-controlling interests

 

(424)

 

185

 

 

1

 

 

 

 

 

(238)

Net (loss) income attributable to Icahn Enterprises

$

(386)

$

218

$

(9)

$

11

$

3

$

(1)

$

(4)

$

(371)

$

(539)

Supplemental information:

 

Capital expenditures

$

$

100

$

21

$

7

$

2

$

1

$

$

$

131

Depreciation and amortization

$

$

173

$

41

$

14

$

6

$

3

$

14

$

$

251

Schedule of Condensed Financial Statements by Segment

June 30, 2024

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

8

$

586

$

89

$

5

$

26

$

4

$

30

$

1,470

$

2,218

Cash held at consolidated affiliated partnerships and restricted cash

 

3,256

 

 

7

 

 

3

 

3

 

 

173

 

3,442

Investments

 

2,196

 

96

 

 

 

14

 

 

 

 

2,306

Accounts receivable, net

 

 

298

 

34

 

87

 

17

 

28

 

30

 

 

494

Inventories, net

 

 

543

 

198

 

115

 

 

92

 

22

 

 

970

Related party notes receivable, net

7

7

Property, plant and equipment, net

 

 

2,542

 

817

 

126

 

367

 

53

 

 

4

 

3,909

Goodwill and intangible assets, net

 

 

169

 

331

 

22

 

 

19

 

184

 

 

725

Other assets

 

2,762

 

288

 

488

 

94

 

67

 

18

 

6

 

194

 

3,917

Total assets

$

8,222

$

4,522

$

1,964

$

449

$

494

$

217

$

272

$

1,848

$

17,988

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

1,225

$

1,438

$

816

$

126

$

54

$

43

$

55

$

92

$

3,849

Securities sold, not yet purchased, at fair value

 

2,128

 

 

 

 

 

 

 

 

2,128

Debt

 

 

1,584

 

27

 

139

 

1

 

14

 

 

4,860

 

6,625

Total liabilities

 

3,353

 

3,022

 

843

 

265

 

55

 

57

 

55

 

4,952

 

12,602

Equity attributable to Icahn Enterprises

 

2,946

 

785

 

1,121

 

168

 

434

 

160

 

217

 

(3,104)

 

2,727

Equity attributable to non-controlling interests

 

1,923

 

715

 

 

16

 

5

 

 

 

 

2,659

Total equity

 

4,869

 

1,500

 

1,121

 

184

 

439

 

160

 

217

 

(3,104)

 

5,386

Total liabilities and equity

$

8,222

$

4,522

$

1,964

$

449

$

494

$

217

$

272

$

1,848

$

17,988

December 31, 2023

Investment

Energy

Automotive

Food
Packaging

Real
Estate

Home
Fashion

Pharma

Holding
Company

Consolidated

(in millions)

ASSETS

Cash and cash equivalents

$

23

$

1,179

$

104

$

8

$

22

$

5

$

26

$

1,584

$

2,951

Cash held at consolidated affiliated partnerships and restricted cash

 

2,799

 

7

 

9

 

 

4

 

3

 

 

173

 

2,995

Investments

 

2,898

 

100

 

 

 

14

 

 

 

 

3,012

Accounts receivable, net

 

 

286

 

41

 

89

 

16

 

26

 

27

 

 

485

Related party note receivable, net

11

11

Inventories, net

 

 

604

 

228

 

111

 

 

81

 

23

 

 

1,047

Property, plant and equipment, net

 

 

2,594

 

822

 

134

 

363

 

52

 

 

4

 

3,969

Goodwill and intangible assets, net

 

 

179

 

335

 

23

 

 

19

 

198

 

 

754

Other assets

 

4,425

 

310

 

480

 

101

 

69

 

17

 

8

 

224

 

5,634

Total assets

$

10,145

$

5,259

$

2,019

$

466

$

488

$

203

$

282

$

1,996

$

20,858

LIABILITIES AND EQUITY

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

  

 

Accounts payable, accrued expenses and other liabilities

$

1,312

$

1,553

$

890

$

148

$

43

$

42

$

55

$

62

$

4,105

Securities sold, not yet purchased, at fair value

 

3,473

 

 

 

 

 

 

 

 

3,473

Debt

 

 

2,185

 

33

 

133

 

1

 

8

 

 

4,847

 

7,207

Total liabilities

 

4,785

 

3,738

 

923

 

281

 

44

 

50

 

55

 

4,909

 

14,785

Equity attributable to Icahn Enterprises

 

3,243

 

795

 

1,096

 

168

 

439

 

153

 

227

 

(2,913)

 

3,208

Equity attributable to non-controlling interests

 

2,117

 

726

 

 

17

 

5

 

 

 

 

2,865

Total equity

 

5,360

 

1,521

 

1,096

 

185

 

444

 

153

 

227

 

(2,913)

 

6,073

Total liabilities and equity

$

10,145

$

5,259

$

2,019

$

466

$

488

$

203

$

282

$

1,996

$

20,858

Energy  
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2024

    

2023

    

2024

    

2023

(in millions)

Petroleum products

$

1,833

$

2,054

3,568

$

4,114

Nitrogen fertilizer products

 

133

 

183

 

261

 

409

$

1,966

$

2,237

$

3,829

$

4,523

Automotive Segment  
Disaggregation of Revenue [Line Items]  
Disaggregation of Revenue

Three Months Ended June 30, 

Six Months Ended June 30, 

    

2024

    

2023

    

2024

    

2023

(in millions)

Automotive Services

$

363

$

392

$

719

$

761

Aftermarket Parts

 

5

 

20

 

18

 

92

Total revenue from customers

$

368

$

412

737

853

Lease revenue outside the scope of ASC 606

15

13

30

29

Total Automotive net sales and other revenues from operations

$

383

$

425

$

767

$

882